A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Oncoinvent Solutions AS
Oncoinvent Solutions AS
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
University of Iowa
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Hospices Civils de Lyon
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Lumicell, Inc.
Seagen Inc.
University of Kentucky
Hospices Civils de Lyon
Hospices Civils de Lyon
Seoul National University Hospital
Assistance Publique - Hôpitaux de Paris
Adichunchanagiri Institute of Medical Sciences, B G Nagara
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Corcept Therapeutics
GE Healthcare
University of Chicago
Columbia University
Swiss GO Trial Group
Vilnius University
Institut Bergonié
Oncoinvent Solutions AS
Arsenal Biosciences, Inc.
University Hospital, Geneva
University of California, Irvine
Institut de Cancérologie de Lorraine
The Netherlands Cancer Institute
University Hospital, Ghent
Hoffmann-La Roche
Ohio State University
New Mexico Cancer Research Alliance
M.D. Anderson Cancer Center
Genelux Corporation
Corcept Therapeutics
Jules Bordet Institute
Laval University
Laval University
National Institutes of Health Clinical Center (CC)
Boehringer Ingelheim
Institut du Cancer de Montpellier - Val d'Aurelle
National Institutes of Health Clinical Center (CC)
Assistance Publique - Hôpitaux de Paris
Catharina Ziekenhuis Eindhoven
Duke University
OncoNano Medicine, Inc.